Patent Information

Name of Invention: Decomposition accelerators for enhanced recycling (Patent No. 7627991)

This patent has been granted as a result of the evidence uncovered through the research efforts of Fordays Co., Ltd.
Fordays Co., Ltd. holds the rights to this patent. While this patent reflects our dedicated research endeavors, it does not guarantee the effects or efficacy of food products. We request that this information not be utilized for business or similar activities.

Name of Invention: Accelerating and methodizing the proliferation of neural stem cells (Patent No. 7554420)

This patent was granted in 2023 and pertains to the substances identified in the invention entitled “Accelerating and methodizing the proliferation of neural stem cells” (Patent No. 7284955). The distinctiveness of these substances resides in the following components: “terminally phosphate-removed trinucleotide CCC,” “terminally phosphate-removed oligonucleotide C6,” “terminally phosphate-removed oligonucleotide C12,” and the modified “trinucleotide CsCsC.” A substance patent is awarded for newly developed compounds and is considered an “invention” under the provisions of the Patent Act.
This patent results from collaborative research between Fordays Co., Ltd. and Professor Yukio Kato of Kanazawa University.
Fordays Co., Ltd. holds the rights to this patent. While this patent reflects our dedicated research endeavors, it does not guarantee the effects or efficacy of food products. We request that this information not be utilized for business or similar activities.

Name of Invention: Capillary angiogenesis agent and method for generating capillaries using hydrolyzed DNA (Patent no.: 7411938)

This patent, was granted based on the compelling evidence discovered through a collaborative research effort between Fordays Co., Ltd. and the esteemed Kobe University Professor Hidemi Fujino. It stands as a testament to our joint commitment to innovation and originality.
Fordays Co., Ltd. holds this patent, underscoring our authority over this invention. While this patent is the result of our dedicated research, we must stress that it does not guarantee the effectiveness or efficacy of Natural DN Collagen, and we strongly discourage its use for business activities.

Name of Invention: Anti-obesity drug and health supplement containing tripeptide RPR

This patent is based on the discovery of novel and original functionalities, and was granted based on the evidence discovered through joint research between Fordays Co., Ltd. and Senior Professor Satoshi Nagaoka of Gifu University. All rights pertaining to this patent is the property of Fordays Co., Ltd. This patent was obtained partly due to our earnest research and not intended to guarantee the effects/efficacy of our supplements. We strongly advise not to use this information for business activities.

Name of Invention: Accelerating and methodizing the proliferation of neural stem cells

This patent is based on the discovery of novel and original functionalities, and granted based on the evidence discovered through joint research between Fordays Co., Ltd. and Kanazawa University. All rights pertaining to this patent is the property of Fordays Co., Ltd. This patent was obtained partly due to our earnest research and not intended to guarantee the effects/efficacy of our supplements. We strongly advise not to use this information for business activities.

Name of Invention: Method for measuring nucleotides, nucleosides and/or bases derived from nucleic acids (DNA and RNA)

This patent establishes a new analysis method for nucleic acid components to further improve the quality of our products. All rights pertaining to this patent is the property of Fordays Co., Ltd. and Life Science Institute.

Name of Invention: Health drink containing cysteine peptide

This patent is a patent for a health drink based on a specific formulation and is applicable to the current “Natural DN Collagen”.
This patent was obtained for the purpose of avoiding sale of similar or counterfeit products in order to guarantee the product’s uniqueness. This information does not guarantee the effects/efficacy of this product. We strongly advise not to use for business activities.

Other patents
(Patent No.: 6153736, Patent No.: 5820127)

These patents are based on the discovery of innovative and original functionalities from the evidence provided by the joint research between Fordays Co., Ltd. and Showa University.
This data belongs to Fordays Co., Ltd. The current Natural DN Collagen is applicable for each claim of this patent. Although these patents are part of the results of our earnest research efforts, they do not guarantee the effects and efficacy of this product, and we advise not to use them for business activities.

Name of Invention: Health drink with water-soluble nucleoprotein

This patent is a composition patent with a patented formulation. The data provided is based on the results of joint research between Life Science Institute and Fordays Co., Ltd.
This patent was obtained for the purpose to avoid the sale of similar or counterfeit products and to guarantee the product’s uniqueness. This information does not guarantee the effects/efficacy of this product. We strongly advise not to use for business activities.

• We have obtained patents in South Korea and China with similar content.
• The current “Natural DN Collagen” has significantly increased vitamins; the following patents are not applicable.